Reply to Amirav and Newhouse: PC<sub>20</sub> versus PD<sub>20</sub>: Why Change a Scientifically Well-Established and Clinically Relevant Test?

Kaminsky, David; Coates, Allan; Culver, Bruce; Cockcroft, Donald; Hallstrand, Teal; Haynes, Jeffrey; MacIntyre, Neil; Wanger, Jack

Reply to Amirav and Newhouse: PC₂₀ versus PD₂₀: Why Change a Scientifically Well-Established and Clinically Relevant Test?

Kaminsky, David; Coates, Allan; Culver, Bruce; Cockcroft, Donald; Hallstrand, Teal; Haynes, Jeffrey; MacIntyre, Neil; Wanger, Jack.

Afiliação

Kaminsky D; 1 University of Vermont College of Medicine Burlington, Vermont.
Coates A; 2 University of Toronto Toronto, Ontario, Canada.
Culver B; 3 University of Washington Seattle, Washington.
Cockcroft D; 4 University of Saskatchewan Saskatoon, Saskatchewan, Canada.
Hallstrand T; 3 University of Washington Seattle, Washington.
Haynes J; 5 St. Joseph Hospital Nashua, New Hampshire.
MacIntyre N; 6 Duke University Medical Center Durham, North Carolina and.
Wanger J; 7 Pulmonary Function Testing and Clinical Trials Consultant Rochester, Minnesota.

Am J Respir Crit Care Med ; 199(8): 1038, 2019 04 15.

Article em En | MEDLINE | ID: mdl-30640508

Assuntos

Broncoconstritores; Nebulizadores e Vaporizadores; Testes de Provocação Brônquica; Cloreto de Metacolina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nebulizadores e Vaporizadores / Broncoconstritores Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google